Background. Balloon expandable intravascular stents have been used to support vessel walls in coronary and peripheral arteries in adults. The purpose of this study was to examine the efficacy and safety of these stents in the treatment of congenital heart disease.
Methods and Results. Forty-five stents were placed in 30 patients, who were 0.2-30.2 years old (weight, 3.5-76 kg). Patients with areas of stenosis that were difficult to approach surgically were chosen. Stents were mounted over balloons and placed by standard catheterization techniques. Twenty-three patients had branch pulmonary artery stenosis. Thirty-six stents were placed successfully and had reduced pressure gradients from 50.6+24 to 15.9±+13.4 mm Hg. Five patients had stents placed after atrial surgery: three in obstructed Fontan repairs, one at the superior vena cava-right atrial junction after sinus venous defect repair, and one at the site of a Glenn shunt. Atrial stents reduced pressure gradients from 9.8±+8.2 to 2.0+2.6 mm Hg. One patient had a stent placed in the descending aorta after coarctation dilation, and the pressure gradient was reduced from 50 to 25 mm Hg. One patient had pulmonary vein dilation with stent placement. Two stents migrated at the time of placement; one required surgical removal, and one was anchored in place by balloon dilation. One patient died within 24 hours of catheterization because of thrombus obstruction of the Fontan repair. Nine patients have undergone recatheterization. All stented vessels have remained at the same caliber as at original stent placement.
Conclusions. We conclude that balloon expandable stents are useful in selected postoperative stenoses in congenital heart disease. (Circulation 1991; 83:1923 -1939 B alloon expandable intravascular stents have been used with success to support vessel walls after dilation in the coronary and peripheral circulations in adults.12 The Palmaz stent (Johnson and Johnson Interventional Systems, Som- merville, N.J.)3-5 has been studied by Mullins et a16 in pulmonary arteries and systemic veins in experimental animals. The purpose of the present study was to evaluate the feasibility, safety, and efficacy of balloon expandable intravascular stents for treatment of congenital or postoperative stenoses in children and young adults with congenital heart disease.
Many patients with congenital heart defects have hemodynamically significant narrowings of branch pulmonary arteries. Attempts at surgical revision of these areas of stenoses are rarely rewarding.7-9 Stenoses of the pulmonary artery branches may lead to high risk for sudden death in patients who have undergone repair of tetralogy of Fallot. 10 Balloon dilation of pulmonary arterial stenosis has been successful in achieving lasting relief in only 60% of cases." Failure is commonly due to vessel compliance; although the stenotic areas can often be dilated to three to four times their original size, the natural recoil of the tissues combined with scarring after operation has caused immediate restenosis in many patients. Complications have been attributed to the necessity for marked overdilation of the stenotic areas to achieve a lasting result." ',12 tion. If these branch pulmonary arteries and other vascular stenoses were able to be dilated temporarily with balloons, only to have the stenoses recur after balloon withdrawal, then such supportive stents may allow lasting relief from these narrowings. Methods 
Patient Selection
The studies were artery. Patient B3 had stent implantation in the area of a long-segment thoracic coarctation of the aorta after attempted balloon dilation.
Patients H10, H14, and H19 in the pulmonary group previously underwent a Fontan operation. They had distal stenoses at the site of previous shunts or in the very proximal branch pulmonary arteries after the Fontan operation. All The stents were constructed of stainless steel 0.076 mm in thickness. The prototypes are 3 cm in length ( Figure 1 ) and 3.4 mm in diameter before expansion, so-called "iliac" stents. The stents used in this investigation had 10 rows of staggered offset slots 6 mm long. For placement, the stents were slid over the deflated balloon of a balloon dilation catheter, and the balloon and stent were expanded by inflation under pressure. The stent expanded with the balloon to the limit of expansion of the balloon. The stents were designed to be dilated to 10-15 mm; dilation to 18-20 mm has been possible in larger vessels. There was some shortening of the stents with expansion; at 18 mm diameter, the stent shortened to 22 mm (27%). After formed to determine the flow percentages to the right and left lungs.
Right (and where indicated left) heart catheterization was performed from the femoral approach, and measurements were obtained of pressure and size of target stenoses and their distal and proximal vessels. The areas of stenoses were defined with angiograms, often by use of reference marks on a marker catheter (Cardiomarker, USCI, Billerica, Mass.). After the size of the stenosis and proximal and distal portions of the affected artery or vein had been estimated, a Teflon-coated guide wire was introduced into position across the stenosis. A balloon catheter was chosen so that the balloon diameter when inflated was 3-4 times the size of the narrowest diameter of the stenosis or equal to the size of the segment distal to the narrowing, whichever was smaller. The lesion was dilated first by use of standard balloon dilation techniques; then the initial dilation catheter was removed, leaving the guide wire in place. Follow-up angiography was performed. In the absence of lasting stenosis relief or in any patient with documented late restenosis, stent placement was undertaken. Among those patients with initially unsuccessful dilations, the diameters of the arteries and other stenotic areas after balloon dilation and before stent implantation were identical to predilation diameters. Stent placement was planned in all patients except the one with coarctation dilation. The initial balloon dilations were considered unsuccessful when the area of stenosis did not remain expanded to the diameter of the vessel distal or proximal to the stenosis, whichever was smaller. No patient had lasting relief of narrowing after balloon dilation, and therefore stents were placed in all.
An 11F or 12F long transseptal sheath and dilator set were advanced over the guide wire into position well across the narrowing. In most cases, this involved changing the initial Teflon-coated exchange guide wire for an Amplatz SuperStiff Teflon-coated exchange wire (Medi-Tech, Inc., Watertown, Mass.). This wire was positioned so that the stiff supportive section of the wire extended across the stenosis. Care was taken during the placement of the long sheath to avoid kinking of the sheath during the passage through the heart and across the stenotic area. The dilator was removed from the sheath, leaving the wire and sheath in place. This removal of the dilator required careful attention to hemostasis, and hemostasis valves for wires (Cordis, Miami, Fla.) were used on the back of the dilator during its insertion. Rubber-shod clamps were used to compress the sheath around the wire immediately on removal of the dilator, and then the hemostasis valves were reloaded over the wire onto the end of the sheath. During each catheter or dilator change that required opening the sheath, the rubber-shod clamps were used to facilitate hemostasis.
The balloon catheter used for installation of the stent was removed from the package and prepared in the standard fashion to eliminate air from the balloon. The balloon was refolded during deflation to reform the configuration it had in the package. The balloon size was chosen to be 10-12 mm in general, for initial implantation of the stent. This allowed adequate expansion of the stent to fix it against stenoses ranging from 3 to 8 mm. The balloon lengths were 3-4 cm to accommodate the unexpanded length of stent. The stent was slid over the distal end of the catheter, maintaining the balloon fold, until the radio-opaque markers on the balloon were an equal distance from ends of the stent (Figure 2) . A plastic sleeve enclosed with the stent was slid over the stent-balloon assembly, and the stent was crimped by hand onto the balloon using this plastic sleeve. The balloon and stent were withdrawn from the crimping sleeve and inspected manually and visually to ensure proper placement of the stent and to assess possible damage to the balloon or stent. In some cases in which a number of curves had to be negotiated by the balloon and stent through the long sheath, the stent was actually positioned slightly more toward the distal end of the balloon so that it might not be pushed too far proximal if it did meet some resistance on traversing the sheath.
In a number of cases, before loading the stent on the balloon the operators introduced the flushed and refolded balloon portion of the catheter through the hemostasis valve of an l1F Touhey-Borst sheath (USCI) built-on hemostasis valve. These hemostasis valves were obtained by cutting a long sheath crosswise approximately 8-10 cm distal to the hemostasis valve. The balloon catheter was advanced through the hemostasis valve and out the stump of the sheath, and the stent was loaded as described above. Then the rubber-shod clamps were applied to the sheath again, and the Cordis hemostasis valve for the wire was removed. The balloon stent-improvised hemostasis valve was advanced over the wire and into the sheath. Because of the use of a slightly more thinwalled material, the 11F Touhey-Borst sheath slid snugly into the 12F or even 1iF standard USCI long sheath, and the adjustable hemostasis valve was tightened around the shaft of the balloon catheter, providing hemostasis. The side arm of the hemostasis valve was allowed to bleed back to evacuate air and clot from the apparatus and then was attached to a flush system. With the sheath and wire held in place, the balloon catheter with stent was advanced over the wire and into position across the stenotic area. At no time did the stent and balloon apparatus travel outside the sheath until it reached the area distal to the stenosis. This minimized the possibility of the stent catching on a venous or cardiac structure and becoming dislodged. When the stent was in place and centered at the stenosis, the sheath was withdrawn gradually, leaving the stent and balloon ready for inflation. Repeated confirmation of the positioning of the stent was obtained by injection of contrast material through the sheath proximal to the stent or through a catheter in place in the area of interest, generally from the opposite femoral vein. The balloon was inflated by hand with dilute contrast material to a pressure of 3.1-6 atm, depending on the recommended inflation pressure for the balloon catheter. The inflation was held at full pressure for 6-10 seconds or until the narrowing in the balloon disappeared. The stent expanded as the balloon was inflated and remained expanded after balloon deflation. The stent expanded from the ends toward the middle (Figure 3 ), facilitating its anchoring at the site of the stenosis. The inflation was repeated until full expansion of the stent to the size of the balloon was seen. In those cases in which dilation was required to be greater than the initial balloon diameter, according to the operator's judgment, the balloon catheter and sheath were removed, leaving the guide wire in place. A larger balloon catheter was advanced over the wire directly through the skin and was positioned in the stent. Repeated FIGURE 3 . With inflation of the balloon, the stent expands from the distal and proximal ends toward the middle. inflation generally resulted in expansion of the stent further to the diameter of the chosen balloon. If there was a persistent waist in the balloon and stent at any inflation diameter, a larger diameter was not used. On rare occasions, a higher pressure balloon of the same diameter was used in an attempt to relieve the residual stenosis. When the desired expansion had been reached, postplacement angiography was performed with measurement of pressures distal and proximal to the dilated segment where possible. Occasionally, during catheter manipulation the wire or catheter inadvertently was withdrawn proximal to the area of the stent, and it was difficult to recross the stent because of the angle of attack. In those cases, measurements of distal pressure after stent placement were not obtained. Measurement of pressure in the chamber proximal, generally the right ventricle, was performed after stent placement. An intravenous line was placed in the hand, and all catheters and sheaths were removed.
During the catheterization, precautions to prevent loss of the device included keeping the guide wire through and beyond the stent at all times during delivery. In the case of a stent moving freely, which occurred twice in this series, the delivery balloon catheter or a catheter with a different size balloon was advanced over the guide wire to try to slide the balloon within the device and capture the stent by inflating the balloon gently. Because of the design of the stent, we anticipated that it would be difficult or impossible to perform transcatheter retrieval of an embolized stent.
Heparin was used in the flush solution during catheterization at a concentration of three units of heparin per milliliter of flush solution. Systemic anticoagulation by means of heparin bolus was not administered routinely in Houston but was administered (100 units/kg) in Boston.
Cefazolin 12.5 mg/kg was administered intravenously at the time of the stent placement and every 6 hours for three doses thereafter. This was chosen as prophylaxis to prevent infection of the initial implant.
In Houston, aspirin (325 mg p.o. once a day) and dipyridamole 25-75 mg p.o. t.i.d. were given at the time of discharge. The current plan is to continue these antiplatelet drugs indefinitely to protect the stents against thrombus formation. In Boston, all patients with venous stents were given warfarin to maintain a prothrombin time, at 1.5-2 times control, for at least 6 months.
Statistical Analysis
On the day after catheterization, pulmonary perfusion scanning was repeated where indicated. A paired t test was used to compare data before and after catheterization. Data are mean+SD.
Results
Forty-five stents were placed in 30 patients ( Table  2) . The results are subdivided into pulmonary and atrial uses. Individual indications and outcome summaries are given in Table 3 .
Pulmonary Artery Placement of Stents
Thirty-five stents were placed in twenty-three patients in the pulmonary arteries. In those patients in whom pressure gradients were measured before and after stent placement, the arterial stenosis gradient fell from an average of 50.6±24 mm Hg before catheterization to an average of 15.9±13.4 mm Hg after catheterization (p0.01). This does not include the patient with bilateral branch pulmonary artery stenosis and hypoplasia (H4), in whom the pressure proximal to the pulmonary artery branches was more than 200 mm Hg, and distal pressure approximated a wedge pressure of 10 mm Hg. The diameters of the arteries before and after catheterization and stent placement increased from 4.6+2.8 to 10.9+4.2 mm (p'O.Ol).
In the eleven patients who had undergone balloon dilation of the unilateral branch pulmonary artery stenosis and who had undergone pulmonary perfusion scanning before and after stent placement, the flow ratio to the affected lung and to the nonaffected lung changed from 26±19% and 74%, respectively, before stent placement to 48+17% and 52%, respectively, after stent placement (pO0.01). In some patients, probably because of mild degrees of pulmonary vascular obstructive disease on the nonstenotic side, there was actually a reversal of the flow ratio, so that the stented side received more of the cardiac output after catheterization. Figures 4 and 5 illustrate results from pulmonary arterial stent placements.
Atrial Placement of Stents
Seven stents were placed in six patients in atrial locations ( Figure 6) . One of these patients also had a stent placed in the left pulmonary artery. Pressure gradients across the atrial stenoses fell from an average of 9.8±8.2 to 2.1±2.6 mm Hg with stent implantation (p 0.01). The diameters of the stenotic areas within the atrial anastomoses increased from 3.8±1.8 to 11.7±3.8 mm (p<0.01).
Other Placement of Stents
One patient had stent placement in the descending thoracic aorta after balloon dilation had resulted in pronounced tears according to angiography. A significant waist remained in this stent after placement. However, the diameter of the narrowing did increase from 2.3 mm before dilation to 5.5 mm after. The total pressure gradient across the stenotic area and conduit graft decreased from 50 mm Hg systolic to 25 mm Hg. The patient with compassionate-use approval (B8), to undergo catheterization because of pulmonary vein stenoses after total anomalous pulmonary venous return repair, had successful stent placement in the stenotic right and left pulmonary veins. After balloon dilation and stenting of the pulmonary veins, the patient improved symptomatically and was discharged from the hospital receiving oral feedings. She im- immediately to the operating room. He did not survive despite thrombus removal, Fontan revision, and Glenn anastomosis of the superior vena cava to the right pulmonary artery. A postmortem examination was not obtained.
2) In the second patient to undergo catheterization at Texas Children's Hospital, a right pulmonary artery branch stenosis was expanded and stented successfully. Dilation of a more proximal right ventricular outflow tract stenosis was attempted, with stent placement at the same catheterization. The stent was expanded in the distal right ventricular outflow tract, but it could not be seated and eventually became free in the right ventricle, causing occasional premature ventricular contractions. The patient underwent uncomplicated operative removal of the stent; the right ventricular outflow tract was inspected, and no resection or widening was done. The right pulmonary artery did not require additional arterioplasty.
Minor Complications 1) In two patients, there had been compromise of the right upper lobe pulmonary artery when a stent had been placed in the area of a proximal right pulmonary artery stenosis. In one additional patient, placement in the left pulmonary artery after a Fontan operation led to complete occlusion of one of the left pulmonary artery branches. However, in many other cases there was no luminal compromise of branch pulmonary arteries traversed by the stents. Except in the case of branch occlusion, no specific lung perfusion scan abnormalities were detected in the areas of lung supplied by the narrowed arteries.
2) In one patient (H4) one small right lower lobe branch of the pulmonary artery was ruptured by balloon dilation, and contrast material was extravasated into the lung parenchyma. The balloon was removed without further complication. There was no significant hemothorax and no clinical sequelae. This is a known risk and an occasional complication of balloon dilation of branch pulmonary arteries. Rupture occurred with a high-pressure balloon (i.e., 12 atm), and subsequently high-pressure balloons have been used sparingly in distal branch pulmonary arteries.
3) Four balloons ruptured during expansion of the arterial stenosis and stent. None except the one noted above has caused compromise of any branch of the pulmonary artery. In one patient, the balloon ruptured early in the course of stent expansion so that only the proximal end of the stent had begun to flare open. Distal guide wire position was maintained, and the stent position was maintained by advancing the end of the long sheath to the proximal (flared) end of the stent. At that point, the ruptured balloon was replaced with an intact balloon, and the procedure was completed without incident. In another case (H17), the balloon ruptured transversely. The distal balloon fragment came loose from the catheter during attempted removal from the femoral vein. The balloon fragment, which had a radioopaque marker, traveled up the wire into the right atrium and tricuspid valve area. The fragment was retrieved successfully by catheter retrieval techniques from the opposite femoral vein. This complication appeared to be related in part to a defect in the balloon catheter itself that allowed the balloon pieces to become detached from the catheter. The investigators have used care not to inflate a balloon against the sharp edges of an expanded stent if possible.
4) A significant air embolus occurred in one patient (B5). The air, which appeared to enter through a venous sheath in the right arm, moved to the lungs and was absorbed in the pulmonary parenchyma. The sheath had been placed in the arm because of the inability to achieve femoral venous access. There were no clinical sequelae. 5) After expansion in a portion of proximal left pulmonary artery just distal to a postoperative stenosis, one stent could not be seated properly and had moved distally into the proximal left pulmonary artery, which was not stenotic (Patient B4). After the operators attempted to capture the stent by inflating the balloon catheter within it and moving the stent proximally, resistance was met, and the stent was advanced more distally into the proximal left pulmonary artery. This stent, therefore, was inserted lengthwise along the direction of flow against the wall of the proximal left pulmonary artery without causing any stenosis, thrombosis, or other difficulty with that artery. Late follow-up demonstrated persistence of unobstructed flow into the left pulmonary artery. 6) Two patients (H10 and H12) developed intimal flaps during balloon dilation, one in a stenotic left pulmonary artery and one throughout the length of a previously implanted artificial conduit. These flaps protruded into the lumen of the pulmonary circuit. The stent placement itself resulted in pressing or tacking of the intimal flaps against the lateral walls of the pulmonary arteries, with complete resolution of any material in the lumen. Both of these problems occurred during balloon dilation alone without stent placement. Indeed, the placement of the stent turned out to be the treatment of choice in both instances for preventing arterial obstruction.
7) A right pulmonary artery thrombus developed in patient H9. Before balloon dilation and stent placement, the presence of a diagnostic catheter itself across the very tight stenosis resulted in stagnation of the right pulmonary artery blood and thrombus formation (Figure 7) . The thrombus was treated with heparin administered into the pulmonary artery, and when flow was restored by stent placement, the thrombus resolved completely. No thrombolytic agents were required. Clinical Follow-up Patients were followed up for 1 day to 9 months, with an average follow-up of 7 weeks. Nine patients underwent recatheterization, and pressure measurements and angiography were repeated at an average of greater than 4 months after stent placement. The angiographic appearance of the stented vessels has remained constant (Figure 8) , and there has been no evidence of restenosis or late thrombus. Pressure gradients measured across the areas of stent placement have remained minimal. Two patients had redilation of four stents 4-6 months after initial placement. In all four stents, the diameters increased (1-3 mm) at redilation. There has been no evidence of aneurysm formation, fistulization, or other problems.
There have been no complications, infections, thromboses, emboli, or other problems related to the stent placement throughout the entire follow-up. There have been no late deaths and no episodes of endocarditis in the 29 surviving patients.
Discussion
Balloon expandable stents are useful in selected postoperative stenoses in children and young adults with congenital heart disease. They have been instrumental in achieving excellent relief of severe stenoses in this initial series of patients. Pressure However, the possibility of the stent becoming part of a fixed and inoperable stenosis in the future must be considered. Prior vessel dilation, either at a previous catheterization or at the same catheterization before stent implantation, is essential. This serves to prove that 1) the stenosis can be enlarged at least temporarily with a balloon dilation technique and 2) the narrowing recurs immediately on deflation of the balloon. The next important technique requirements are to have two venous catheters in place, one for stent delivery over a wire and one for repeated angiographic confirmation of the stenosis appearance and the location of the stent with respect to the narrowest point. In general, the stents have been centered on the stenosis as closely as possible. This facilitates anchoring of the stent as it expands from the ends toward the middle. Once the guide wire is across the stenosis it should be left in place, as with all repetitive catheter changes after balloon dilation. The stiff wire to support the large diameter sheath has been essential in enabling the sheath to negotiate the turns required to cross the target area. The catheterization laboratories involved in these implantations have had access to large selections and quantities of wires, catheters, and sheaths, along with immediately available back-up services of cardiovascular anesthesia and cardiovascular surgery.
There is preliminary work in progress in animals showing that stents, once placed, may be able to be dilated after growth of the animal and blood vessel. This potential for late stent redilation has been observed in four stents in this series. This ability to redilate stents would be very important and helpful in growing children. For the present, it is recommended that stents be considered primarily in patients whose vessels distal and proximal are of a size that would permit expansion of the stent to a diameter that will be sufficient for adolescence and adulthood. The stent used in this investigation may be made shorter to treat discrete ostial stenosis. This shortening would make the stent somewhat more difficult to center on the lesion. The maximum dilated internal diameter of the stent used is approximately 20 mm; there could be larger internal diameter models in the future, but their placement might be complicated by the need for very large balloon catheters.
Distal branch pulmonary artery stenoses may be able to be treated with multiple stent placements; in some cases, smaller stents such as those designed for coronary and renal arteries may be useful. It is expected that stents will be able to be overlapped in series to afford support of long-segment stenoses after balloon dilation. This technique was used in one patient (H1) in this series. The need for and type of anticoagulation will also require further investigation. It is planned that the patients will continue to receive aspirin and dipyridamole indefinitely, although long-term follow-up may show that these antiplatelet drugs are either not required or, less likely, not sufficient. More experience with patients with various types of stenoses, and especially continued follow-up, will be required. Nonetheless, we think it likely that this promising mode of treatment will continue to gain a position in the therapeutic cardiac catheterization laboratory for patients with congenital heart disease.
